Phenoxybenzamine HCl 15 mg/ml Transdermal Cream

Phenoxybenzamine HCl 15 mg/ml Transdermal Cream is a specially compounded medication designed to deliver a specific dose of phenoxybenzamine hydrochloride through the skin. Phenoxybenzamine is a non-selective, irreversible alpha-adrenergic antagonist, which works by causing vasodilation and decreasing peripheral vascular resistance. This mechanism of action makes it particularly useful in the treatment of conditions such as pheochromocytoma, where it is used preoperatively to control hypertension by blocking the effects of catecholamines secreted by the tumor. Additionally, it has been used off-label for conditions like Raynaud's phenomenon and certain types of hyperhidrosis, where its vasodilatory effects can alleviate symptoms.

The transdermal cream formulation provides a convenient and controlled method of application, allowing for localized treatment with the potential for systemic absorption. The semisolid preparation is dispensed in a pump mechanism, which ensures consistent dosing and minimizes the risk of contamination. This dosage form is particularly beneficial for patients who may have difficulty swallowing pills or for those who require a steady release of medication over an extended period.

For patients, it is important to understand that the use of this transdermal cream should be under the guidance of a healthcare professional. The area of application should be clean and free from cuts or irritations to prevent any adverse reactions. Patients should also be aware of the potential side effects, which may include nasal congestion, fatigue, dizziness, or gastrointestinal discomfort. It is crucial to adhere to the prescribed dosage and application instructions to ensure optimal treatment outcomes.

Prescribers considering this formulation for their patients should be aware of the potential for systemic absorption and the need to monitor for systemic side effects. Additionally, they should consider the patient's overall medication profile to avoid interactions, particularly with other antihypertensive agents or drugs that may affect heart rate or blood pressure. Dose adjustments may be necessary based on the patient's response and any concurrent medications.

If you have any questions or require further information about Phenoxybenzamine HCl 15 mg/ml Transdermal Cream, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of this specialized medication.

Phenoxybenzamine HCl is an alpha-adrenergic blocker that is used to manage conditions such as pheochromocytoma by controlling episodes of hypertension and sweating. When formulated as a 15 mg/ml transdermal cream, it is intended for localized treatment, potentially reducing systemic side effects. However, it is important to consider drug interactions, as they can affect the efficacy and safety of the treatment.

Phenoxybenzamine can interact with other alpha-blockers, leading to additive hypotensive effects. Caution is advised when co-administering with drugs such as prazosin, terazosin, or doxazosin. Patients should be monitored for signs of hypotension, and dose adjustments may be necessary. Similarly, concurrent use with beta-blockers like propranolol should be approached with caution, as phenoxybenzamine may exacerbate the reflex tachycardia caused by beta-blockade.

Patients taking drugs that affect the cytochrome P450 enzyme system, particularly CYP2D6, may experience altered metabolism of phenoxybenzamine. Inhibitors of CYP2D6, such as fluoxetine and paroxetine, could potentially increase phenoxybenzamine levels, while inducers like rifampin may decrease its efficacy. Careful monitoring and possible dose adjustments are recommended when these drugs are used concomitantly.

Phenoxybenzamine may enhance the effects of antihypertensive agents and vasodilators, leading to an increased risk of severe hypotension. Patients should be closely monitored, and dosage adjustments of the antihypertensive medication may be necessary. Additionally, the use of phosphodiesterase-5 inhibitors, such as sildenafil, tadalafil, or vardenafil, in combination with phenoxybenzamine, may result in significant hypotension and is generally not recommended.

Patients receiving general anesthetics should inform their anesthesiologist that they are using phenoxybenzamine, as it may interfere with the effects of certain anesthetics, necessitating dose adjustments during surgical procedures. The use of alcohol or CNS depressants with phenoxybenzamine may also enhance the sedative effects, and caution is advised.

It is important to note that while the transdermal route of administration may reduce systemic exposure, systemic absorption can still occur, and the potential for drug interactions exists. Patients should be advised to inform all healthcare providers, including their pharmacist, of all medications they are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

If you have any questions or require further information regarding drug interactions with phenoxybenzamine HCl transdermal cream, please do not hesitate to reach out to us at Bayview Pharmacy. Our team is committed to ensuring the safe and appropriate use of this medication.

Phenoxybenzamine HCl 15 mg/ml Transdermal Cream is a specially formulated medication that is designed to deliver the active ingredient, phenoxybenzamine hydrochloride, through the skin and into the bloodstream. Phenoxybenzamine is a non-selective, irreversible alpha-adrenergic antagonist, which means it blocks the alpha-adrenergic receptors in the body. By doing so, it prevents the neurotransmitter norepinephrine (noradrenaline) from binding to these receptors, which leads to a decrease in vascular resistance and an increase in blood flow.

This mechanism of action is particularly beneficial in the treatment of conditions such as pheochromocytoma, a rare tumor of the adrenal gland which can cause high blood pressure, and Raynaud's phenomenon, where blood vessels in the fingers and toes spasm and restrict blood flow. In the case of pheochromocytoma, phenoxybenzamine reduces the hypertensive effects caused by the tumor's secretion of catecholamines. For Raynaud's phenomenon, the vasodilatory effect of phenoxybenzamine can help alleviate the symptoms by improving blood flow to the extremities.

The transdermal cream formulation allows for the medication to be applied directly to the skin, providing a localized effect or allowing the drug to be absorbed into the systemic circulation through the skin. This method of delivery can be advantageous as it may reduce systemic side effects compared to oral administration. The cream is dispensed in a pump mechanism, which offers a convenient and controlled way to administer the medication, ensuring consistent dosing with each application.

It is important for both patients and prescribers to understand that while the transdermal route of administration can offer benefits in terms of ease of use and potentially reduced side effects, it also requires careful consideration of the skin's condition and the area of application. The skin must be intact, without cuts or abrasions, to ensure proper absorption and to prevent irritation or infection. Additionally, patients should be instructed on how to use the pump and apply the cream correctly to maximize the therapeutic effects of the medication.

If you have any questions about the Phenoxybenzamine HCl 15 mg/ml Transdermal Cream, or if you require further information on its use and the conditions it treats, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the support and guidance needed to ensure the safe and appropriate use of this medication.

Phenoxybenzamine HCl, traditionally used orally to manage the hypertension associated with pheochromocytoma, has been formulated into a 15 mg/ml transdermal cream at Bayview Pharmacy to provide an alternative administration route for patients who might benefit from localized treatment. This semisolid preparation, dispensed via a pump mechanism, is particularly useful for its ease of application and controlled dosing on the skin.

In addition to its primary use, this transdermal formulation of phenoxybenzamine HCl can also be considered for other conditions where sympathetic blockade may provide therapeutic benefits. For example, some off-label uses might include complex regional pain syndrome, where the cream may help reduce the localized vasospasm and pain due to its vasodilatory properties. Additionally, by applying phenoxybenzamine transdermally, there might be a reduction in systemic adverse effects compared to the oral route.

Another possible off-label use could be the treatment of dermal ischemia or ulcerations where increased blood flow is desired. Moreover, individuals suffering from Raynaud's phenomenon may experience some symptomatic relief from the localized application of this alpha-blocking agent, as it promotes peripheral vasodilation. However, such uses would be considered experimental and should be approached with caution under the guidance of a healthcare professional.

It is important to note that while there may be promising alternative uses for phenoxybenzamine HCl transdermal cream, more studies are needed to validate its efficacy and safety in these contexts. As compounding pharmacists, we emphasize that this product should be used strictly as directed by a prescriber, and any off-label use must be approached with a full understanding of the potential risks and benefits. We encourage both patients and prescribers with inquiries or who are considering this medication for other indications to reach out to us at Bayview Pharmacy for further information and professional guidance.